Glenmark Pharma Launches First Biosimilar Anti-Diabetic Drug In India; Stock Rises

Business | Jan 04, 2024

Glenmark Pharmaceuticals has launched the first biosimilar of the popular anti-diabetic drug, Liraglutide, in India, which is expecte..